Antiplatelet activity of β-blockers: new light on existing data.
作者信息
Minuz Pietro, Calabria Stefano, Fava Cristiano
机构信息
Department of Medicine, Section of Internal Medicine, University of Verona, Verona, Italy.
出版信息
Br J Clin Pharmacol. 2014 Nov;78(5):937-9. doi: 10.1111/bcp.12438.
Abstract
摘要
相似文献
1
Antiplatelet activity of β-blockers: new light on existing data.β受体阻滞剂的抗血小板活性：现有数据的新见解
Br J Clin Pharmacol. 2014 Nov;78(5):937-9. doi: 10.1111/bcp.12438.
2
Effect of β-blockers on platelet aggregation: a systematic review and meta-analysis.β受体阻滞剂对血小板聚集的影响：一项系统评价和荟萃分析。
Br J Clin Pharmacol. 2014 Nov;78(5):940-9. doi: 10.1111/bcp.12404.
3
Effects of adrenergic blockers on platelet aggregation.肾上腺素能阻滞剂对血小板聚集的影响。
Rev Esp Fisiol. 1979 Sep;35(3):269-72.
4
Platelet aggregation and beta-blockers.血小板聚集与β受体阻滞剂
Lancet. 1982 Jan 23;1(8265):224-5. doi: 10.1016/s0140-6736(82)90790-5.
5
Platelet aggregation, beta-blockers, and migraine.血小板聚集、β受体阻滞剂与偏头痛。
Lancet. 1982 Feb 6;1(8267):337. doi: 10.1016/s0140-6736(82)91590-2.
6
[Inhibition of thrombocyte aggregation by beta blockers. Reduction of collagen-induced thrombocyte aggregation in vitro].β受体阻滞剂对血小板聚集的抑制作用。体外胶原诱导的血小板聚集的降低
Fortschr Med. 1984 Dec 20;102(47-48):1203-5.
7
[Effect of beta-adrenergic receptor blockers on the aggregation and secretory response of blood platelets].β-肾上腺素能受体阻滞剂对血小板聚集及分泌反应的影响
Bratisl Lek Listy. 1987 Feb;87(2):129-38.
8
Vasodilating versus first-generation β-blockers for cardiovascular protection.血管扩张剂与第一代β受体阻滞剂在心血管保护方面的比较。
Postgrad Med. 2012 Mar;124(2):7-15. doi: 10.3810/pgm.2012.03.2532.
9
[Effect of beta-blocking agents on platelet aggregation].β受体阻滞剂对血小板聚集的影响
Pol Arch Med Wewn. 1975 Aug;54(2):203-8.
10
The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients.两种β-肾上腺素能受体阻滞剂（美吲哚洛尔和阿替洛尔）对正常志愿者和原发性高血压患者血脂及血小板聚集的影响。
Br J Clin Pharmacol. 1984 Mar;17(3):361-3. doi: 10.1111/j.1365-2125.1984.tb02355.x.
本文引用的文献
1
Effect of β-blockers on platelet aggregation: a systematic review and meta-analysis.β受体阻滞剂对血小板聚集的影响：一项系统评价和荟萃分析。
Br J Clin Pharmacol. 2014 Nov;78(5):940-9. doi: 10.1111/bcp.12404.
2
Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.比索洛尔刺激血小板产生一氧化氮可预防血栓形成。
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):820-9. doi: 10.1161/ATVBAHA.114.303290. Epub 2014 Feb 20.
3
Beta blockers, nitric oxide, and cardiovascular disease.β受体阻滞剂、一氧化氮与心血管疾病。
Curr Opin Pharmacol. 2013 Apr;13(2):265-73. doi: 10.1016/j.coph.2012.12.002. Epub 2013 Jan 5.
4
Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry.制定北美共识指南，用于指导使用透光比浊法进行和解释血小板功能检测的医学实验室。
Am J Clin Pathol. 2010 Dec;134(6):955-63. doi: 10.1309/AJCP9V3RRVNZMKDS.
5
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.用于报告评估卫生保健干预措施的研究的系统评价和荟萃分析的PRISMA声明：解释与详述
J Clin Epidemiol. 2009 Oct;62(10):e1-34. doi: 10.1016/j.jclinepi.2009.06.006. Epub 2009 Jul 23.
6
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".低剂量阿司匹林对血小板环氧化酶的抑制作用在血小板功能检测中并未始终得到体现：对阿司匹林“抵抗”的启示。
J Am Coll Cardiol. 2009 Feb 24;53(8):667-77. doi: 10.1016/j.jacc.2008.10.047.
7
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.GRADE：关于证据质量评级和推荐强度的新共识。
BMJ. 2008 Apr 26;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.
8
Effects of nebivolol on platelet activation in hypertensive patients: a comparative study with metoprolol.奈必洛尔对高血压患者血小板活化的影响：与美托洛尔的比较研究。
Int J Cardiol. 2007 Mar 20;116(2):206-11. doi: 10.1016/j.ijcard.2006.03.046. Epub 2006 Jul 5.
9
Antiplatelet activity of carvedilol in comparison to propranolol.卡维地洛与普萘洛尔相比的抗血小板活性。
Platelets. 2002 Dec;13(8):479-85. doi: 10.1080/0953710021000057848.
10
Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.β-肾上腺素能受体拮抗剂与人体血小板：效应与脂溶性的关系
Biochem Pharmacol. 1984 Aug 15;33(16):2615-22. doi: 10.1016/0006-2952(84)90634-8.
Zotero 插件